These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15915271

  • 21. [Cardiovascular risk factors and prevention].
    Bongard V, Ferrières J.
    Rev Prat; 2006 Jan 15; 56(1):79-87, 94. PubMed ID: 16548253
    [No Abstract] [Full Text] [Related]

  • 22. Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
    Klein KP, Herrington DM.
    Medscape Womens Health; 2002 Jan 15; 7(5):2. PubMed ID: 12466731
    [No Abstract] [Full Text] [Related]

  • 23. Management of cardiovascular risk in diabetic patients: evolution or revolution?
    Ceriello A, Sechi LA.
    Diabetes Nutr Metab; 2002 Apr 15; 15(2):121-7. PubMed ID: 12059094
    [Abstract] [Full Text] [Related]

  • 24. [Multifactorial approach of the cardiovascular risks in case of diabetes].
    Ducobu J.
    Rev Med Brux; 2005 Sep 15; 26(4):S255-63. PubMed ID: 16240871
    [Abstract] [Full Text] [Related]

  • 25. Hormone alternative doesn't worsen vasomotor symptoms or impact urinary incontinence in post-menopausal women.
    Rollins G.
    Rep Med Guidel Outcomes Res; 2004 Mar 05; 15(5):7-9. PubMed ID: 15025087
    [No Abstract] [Full Text] [Related]

  • 26. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.
    Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, Kaaja R, Mikkola T, Palacios S, Preston R, Simon T, Stevenson J, Stramba-Badiale M.
    Eur Heart J; 2007 Aug 05; 28(16):2028-40. PubMed ID: 17644507
    [Abstract] [Full Text] [Related]

  • 27. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
    Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL, AHA.
    Arterioscler Thromb Vasc Biol; 2004 Mar 05; 24(3):e29-50. PubMed ID: 15003974
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Tibolone therapy in postmenopausal women with a history of many risk factors].
    Szántó F.
    Orv Hetil; 2003 Apr 13; 144(15):701-4. PubMed ID: 12774429
    [Abstract] [Full Text] [Related]

  • 31. [Hormone replacement therapy and cardiovascular prevention. Where are we now?].
    Lerman J, Siseles N.
    Medicina (B Aires); 2008 Apr 13; 68(3):251-7. PubMed ID: 18689159
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Managing cardiovascular risk in menopausal women.
    Rosano GM, Vitale C, Tulli A.
    Climacteric; 2006 Sep 13; 9 Suppl 1():19-27. PubMed ID: 16899440
    [Abstract] [Full Text] [Related]

  • 35. Questioning the cardioprotective action of hormone replacement therapy in postmenopausal women.
    Mascitelli L, Goldstein MR, Pezzetta F.
    J Cardiovasc Med (Hagerstown); 2009 Aug 13; 10(8):657-8. PubMed ID: 19424079
    [Abstract] [Full Text] [Related]

  • 36. The controversy over estrogen replacement therapy: an update on clinical trials.
    Gnatuk CL.
    Curr Womens Health Rep; 2002 Apr 13; 2(2):89-94. PubMed ID: 12116607
    [Abstract] [Full Text] [Related]

  • 37. [Postmenopausal hormone replacement therapy and cardiovascular disease].
    Høibraaten E.
    Tidsskr Nor Laegeforen; 2002 Jun 20; 122(16):1564-5. PubMed ID: 12119783
    [No Abstract] [Full Text] [Related]

  • 38. Hormone replacement therapy in postmenopausal women with diabetes mellitus.
    Thijs A, Stehouwer CD.
    Semin Vasc Med; 2002 May 20; 2(2):215-9. PubMed ID: 16222612
    [Abstract] [Full Text] [Related]

  • 39. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J, Brincat MP.
    Curr Opin Obstet Gynecol; 2008 Dec 20; 20(6):513-8. PubMed ID: 18989125
    [Abstract] [Full Text] [Related]

  • 40. [Effects of SERMs on bone health. Efficacy of SERM for incidence of fractures in osteoporotic patients with lifestyle-related diseases].
    Sakai A, Nakamura T.
    Clin Calcium; 2010 Mar 20; 20(3):322-9. PubMed ID: 20190361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.